Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 59.69 is 44% above its estimated 2-year average of 41.35, around the middle of its estimated 2-year range (9.45–128.34).
As of 2026-10-06T12:05:57.879Z. 27.41% above its estimated 12-month average of 46.85.
Calculation as of: 2026-10-06T12:05:57.879Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5c882cca81b2c0fe2c09916b57b0a50c93804d18514abf2397940823ad07c5bd
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
59.69
PS RATIO AVG TTM
46.85
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+27.41%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.91
median of 270 covered companies
CURRENT VS SECTOR MEDIAN
+1426.60%
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$251.64M
PS Ratio
59.69
TTM Avg
46.85
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.10M
PS Ratio
94.69
TTM Avg
82.20
3Y Avg
35.74
5Y Avg
24.54
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $251.64M | 59.69 | 46.85 | N/A | N/A |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $248.21M | N/A | N/A | N/A | N/A |
| Galectin Therapeutics Inc. (GALT)vs › | $245.65M | N/A | N/A | N/A | N/A |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | 1.11 | 1.71 | 2.09 | 1.59 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $259.30M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | 23.12 | 76.33 | 78.08 | 78.08 |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | 2.19 | 1.86 | 1.92 | 2.22 |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $264.10M | 94.69 | 82.20 | 35.74 | 24.54 |
| Biodesix, Inc. (BDSX)vs › | $236.56M | 2.30 | 1.47 | 2.05 | 2.05 |
| AC Immune S.A. (ACIU)vs › | $275.81M | 12.71 | 46.34 | 33239.72 | 23903.84 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $795,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $348,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-05 |
| Q1 FY2026Period ended 2026-03-31 | $1,294,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-07 |
| Q2 FY2026Period ended 2026-06-30 | $1,779,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $4,216,000 |
Current P/S: $251,640,332 market capitalization ÷ $4,216,000 TTM revenue = 59.69x.
Market capitalization source: FMP quote. Quote observed 2026-10-05T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 59.69, P/S is above its estimated 2-year median — higher than 70% of readings in its estimated 2-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 2-year low
9.45
median
31.84
estimated 2-year high
128.34
P/S Ratio
59.69
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 55.10 |
| 2026-10-02 | 54.96 |
| 2026-10-01 | 52.76 |
| 2026-09-30 | 55.51 |
| 2026-09-29 | 53.73 |
| 2026-09-28 | 52.90 |
| 2026-09-25 | 53.86 |
| 2026-09-24 | 52.76 |
| 2026-09-23 | 51.11 |
| 2026-09-22 | 57.02 |
| 2026-09-21 | 57.30 |
| 2026-09-18 | 58.26 |
| 2026-09-17 | 55.37 |
| 2026-09-16 | 53.04 |
| 2026-09-15 | 57.57 |
| 2026-09-14 | 58.40 |
| 2026-09-11 | 58.40 |
| 2026-09-10 | 59.63 |
| 2026-09-09 | 59.50 |
| 2026-09-08 | 60.46 |
| 2026-09-04 | 60.60 |
| 2026-09-03 | 61.69 |
| 2026-09-02 | 52.21 |
| 2026-09-01 | 52.08 |
| 2026-08-31 | 54.41 |
| 2026-08-28 | 57.02 |
| 2026-08-27 | 56.89 |
| 2026-08-26 | 57.71 |
| 2026-08-25 | 61.14 |
| 2026-08-24 | 59.36 |
| 2026-08-21 | 61.56 |
| 2026-08-20 | 61.28 |
| 2026-08-19 | 63.89 |
| 2026-08-18 | 67.33 |
| 2026-08-17 | 68.70 |
| 2026-08-14 | 74.75 |
| 2026-08-13 | 66.26 |
| 2026-08-12 | 66.70 |
| 2026-08-11 | 61.40 |
| 2026-08-10 | 62.13 |
| 2026-08-07 | 62.43 |
| 2026-08-06 | 66.26 |
| 2026-08-05 | 59.04 |
| 2026-08-04 | 61.25 |
| 2026-08-03 | 61.99 |
| 2026-07-31 | 50.80 |
| 2026-07-30 | 51.09 |
| 2026-07-29 | 48.15 |
| 2026-07-28 | 50.36 |
| 2026-07-27 | 50.36 |
| 2026-07-24 | 46.53 |
| 2026-07-23 | 44.32 |
| 2026-07-22 | 45.79 |
| 2026-07-21 | 46.97 |
| 2026-07-20 | 48.88 |
| 2026-07-17 | 54.63 |
| 2026-07-16 | 57.42 |
| 2026-07-15 | 61.99 |
| 2026-07-14 | 65.52 |
| 2026-07-13 | 66.26 |
| 2026-07-10 | 63.75 |
| 2026-07-09 | 63.90 |
| 2026-07-08 | 61.69 |
| 2026-07-07 | 64.78 |
| 2026-07-06 | 63.02 |
| 2026-07-02 | 65.23 |
| 2026-07-01 | 63.90 |
| 2026-06-30 | 64.34 |
| 2026-06-29 | 65.37 |
| 2026-06-26 | 61.84 |
| 2026-06-25 | 57.72 |
| 2026-06-24 | 59.34 |
| 2026-06-23 | 64.20 |
| 2026-06-22 | 61.84 |
| 2026-06-18 | 60.81 |
| 2026-06-17 | 60.96 |
| 2026-06-16 | 60.81 |
| 2026-06-15 | 58.31 |
| 2026-06-12 | 61.69 |
| 2026-06-11 | 62.13 |
| 2026-06-10 | 63.90 |
| 2026-06-09 | 59.04 |
| 2026-06-08 | 60.22 |
| 2026-06-05 | 60.52 |
| 2026-06-04 | 63.31 |
| 2026-06-03 | 61.40 |
| 2026-06-02 | 58.60 |
| 2026-06-01 | 59.48 |
| 2026-05-29 | 64.64 |
| 2026-05-28 | 66.11 |
| 2026-05-27 | 61.99 |
| 2026-05-26 | 60.37 |
| 2026-05-22 | 66.40 |
| 2026-05-21 | 64.78 |
| 2026-05-20 | 66.26 |
| 2026-05-19 | 61.10 |
| 2026-05-18 | 67.14 |
| 2026-05-15 | 63.46 |
| 2026-05-14 | 64.49 |
| 2026-05-13 | 66.26 |
| 2026-05-12 | 66.26 |
| 2026-05-11 | 64.78 |
| 2026-05-08 | 65.67 |
| 2026-05-07 | 64.40 |
| 2026-05-06 | 60.24 |
| 2026-05-05 | 59.05 |
| 2026-05-04 | 57.27 |
| 2026-05-01 | 60.09 |
| 2026-04-30 | 61.87 |
| 2026-04-29 | 59.50 |
| 2026-04-28 | 63.36 |
| 2026-04-27 | 65.88 |
| 2026-04-24 | 65.88 |
| 2026-04-23 | 65.88 |
| 2026-04-22 | 67.66 |
| 2026-04-21 | 68.55 |
| 2026-04-20 | 66.92 |
| 2026-04-17 | 66.62 |
| 2026-04-16 | 66.77 |
| 2026-04-15 | 68.11 |
| 2026-04-14 | 67.07 |
| 2026-04-13 | 68.85 |
| 2026-04-10 | 66.62 |
| 2026-04-09 | 66.62 |
| 2026-04-08 | 67.96 |
| 2026-04-07 | 69.00 |
| 2026-04-06 | 66.62 |
| 2026-04-02 | 66.32 |
| 2026-04-01 | 66.18 |
| 2026-03-31 | 65.43 |
| 2026-03-30 | 59.35 |
| 2026-03-27 | 63.95 |
| 2026-03-26 | 67.66 |
| 2026-03-25 | 70.48 |
| 2026-03-24 | 67.22 |
| 2026-03-23 | 69.59 |
| 2026-03-20 | 74.19 |
| 2026-03-19 | 76.56 |
| 2026-03-18 | 79.09 |
| 2026-03-17 | 82.35 |
| 2026-03-16 | 81.31 |
| 2026-03-13 | 80.27 |
| 2026-03-12 | 79.83 |
| 2026-03-11 | 83.09 |
| 2026-03-10 | 89.77 |
| 2026-03-09 | 93.18 |
| 2026-03-06 | 62.32 |
| 2026-03-05 | 24.34 |
| 2026-03-04 | 21.63 |
| 2026-03-03 | 20.89 |
| 2026-03-02 | 23.44 |
| 2026-02-27 | 23.81 |
| 2026-02-26 | 23.81 |
| 2026-02-25 | 23.60 |
| 2026-02-24 | 24.92 |
| 2026-02-23 | 23.97 |
| 2026-02-20 | 23.01 |
| 2026-02-19 | 23.60 |
| 2026-02-18 | 21.26 |
| 2026-02-17 | 21.53 |
| 2026-02-13 | 20.41 |
| 2026-02-12 | 23.28 |
| 2026-02-11 | 24.82 |
| 2026-02-10 | 24.07 |
| 2026-02-09 | 22.96 |
| 2026-02-06 | 20.36 |
| 2026-02-05 | 19.04 |
| 2026-02-04 | 18.77 |
| 2026-02-03 | 19.09 |
| 2026-02-02 | 20.04 |
| 2026-01-30 | 19.62 |
| 2026-01-29 | 20.52 |
| 2026-01-28 | 21.21 |
| 2026-01-27 | 20.31 |
| 2026-01-26 | 18.24 |
| 2026-01-23 | 21.26 |
| 2026-01-22 | 24.76 |
| 2026-01-21 | 23.86 |
| 2026-01-20 | 23.54 |
| 2026-01-16 | 29.80 |
| 2026-01-15 | 30.65 |
| 2026-01-14 | 31.39 |
| 2026-01-13 | 32.13 |
| 2026-01-12 | 32.03 |
| 2026-01-09 | 31.44 |
| 2026-01-08 | 32.87 |
| 2026-01-07 | 32.87 |
| 2026-01-06 | 31.76 |
| 2026-01-05 | 31.76 |
| 2026-01-02 | 31.81 |
| 2025-12-31 | 32.50 |
| 2025-12-30 | 31.23 |
| 2025-12-29 | 31.76 |
| 2025-12-26 | 31.60 |
| 2025-12-24 | 31.39 |
| 2025-12-23 | 31.50 |
| 2025-12-22 | 31.81 |
| 2025-12-19 | 33.83 |
| 2025-12-18 | 32.93 |
| 2025-12-17 | 37.81 |
| 2025-12-16 | 37.17 |
| 2025-12-15 | 35.79 |
| 2025-12-12 | 34.41 |
| 2025-12-11 | 31.87 |
| 2025-12-10 | 30.33 |
| 2025-12-09 | 24.39 |
| 2025-12-08 | 19.35 |
| 2025-12-05 | 17.23 |
| 2025-12-04 | 17.98 |
| 2025-12-03 | 17.23 |
| 2025-12-02 | 17.55 |
| 2025-12-01 | 17.18 |
| 2025-11-28 | 20.15 |
| 2025-11-26 | 19.19 |
| 2025-11-25 | 17.92 |
| 2025-11-24 | 17.66 |
| 2025-11-21 | 15.38 |
| 2025-11-20 | 18.61 |
| 2025-11-19 | 19.67 |
| 2025-11-18 | 20.94 |
| 2025-11-17 | 21.16 |
| 2025-11-14 | 21.74 |
| 2025-11-13 | 22.64 |
| 2025-11-12 | 23.28 |
| 2025-11-11 | 21.90 |
| 2025-11-10 | 22.06 |
| 2025-11-07 | 22.54 |
| 2025-11-06 | 29.83 |
| 2025-11-05 | 27.89 |
| 2025-11-04 | 25.28 |
| 2025-11-03 | 26.41 |
| 2025-10-31 | 27.89 |
| 2025-10-30 | 27.02 |
| 2025-10-29 | 25.88 |
| 2025-10-28 | 26.21 |
| 2025-10-27 | 26.15 |
| 2025-10-24 | 24.94 |
| 2025-10-23 | 23.33 |
| 2025-10-22 | 22.33 |
| 2025-10-21 | 22.86 |
| 2025-10-20 | 21.39 |
| 2025-10-17 | 19.64 |
| 2025-10-16 | 20.85 |
| 2025-10-15 | 23.06 |
| 2025-10-14 | 22.66 |
| 2025-10-13 | 24.27 |
| 2025-10-10 | 24.87 |
| 2025-10-09 | 25.41 |
| 2025-10-08 | 23.73 |
| 2025-10-07 | 22.06 |
| 2025-10-06 | 23.13 |
| 2025-10-03 | 20.31 |
| 2025-10-02 | 19.98 |
| 2025-10-01 | 19.78 |
| 2025-09-30 | 20.11 |
| 2025-09-29 | 20.58 |
| 2025-09-26 | 19.98 |
| 2025-09-25 | 20.11 |
| 2025-09-24 | 18.70 |
| 2025-09-23 | 16.89 |
Showing the most recent 260 of 382 data points. The chart above shows the full history.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.